Profiel
Andre van Hoek is currently the Chief Financial Officer & Director at Stalar 3, Inc. and also holds the position of Chief Financial Officer & Director at Stalar 4, Inc. He previously worked at Celgene Corp.
as the Chief Accounting Officer & Controller from 2009 to 2011.
Actieve functies van Andre van Hoek
| Bedrijven | Functie | Begin |
|---|---|---|
Stalar 3, Inc.
 Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Director of Finance/CFO | 24-01-2011 |
Stalar 4, Inc.
 Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Director of Finance/CFO | 25-01-2011 |
Eerdere bekende functies van Andre van Hoek
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Comptroller/Controller/Auditor | 30-06-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Stalar 3, Inc.
Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 4, Inc.
Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
